Patents by Inventor Martin Wax

Martin Wax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060172965
    Abstract: RNA interference is provided for inhibition of ocular hypertension target mRNA expression for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Ocular hypertension targets include carbonic anhydrase II, IV, and XII; ?1- and ?2 adrenergic receptors; acetylcholinesterase; Na+/K+-ATPase; and Na—K-2Cl cotransporter. Ocular hypertension is treated by administering interfering RNAs of the present invention.
    Type: Application
    Filed: February 1, 2006
    Publication date: August 3, 2006
    Applicant: Alcon, Inc.
    Inventors: Allan Shepard, Jon Chatterton, Abbot Clark, Martin Wax
  • Publication number: 20050119262
    Abstract: The present invention provides methods and compositions for the prevention and/or treatment of an optic neuropathy, comprising a Cox-2 inhibitor and an intraocular pressure reducing agent.
    Type: Application
    Filed: August 17, 2004
    Publication date: June 2, 2005
    Applicant: Pharmacia Corporation
    Inventor: Martin Wax
  • Publication number: 20050032691
    Abstract: This invention provides a method for treating a subject with glaucoma comprising the steps of administrating a compound or composition which antagonize, inhibits, inactivates, reduce, suppresses, antagonizes, and/or limits the release, synthesis, or production from cells of TNF-? thereby treating the subject with glaucoma.
    Type: Application
    Filed: March 11, 2004
    Publication date: February 10, 2005
    Inventors: Martin Wax, Gulgun Tezel